Biogen Inc. (BIIB) News Headlines

▮ More

Date

Headline

6/17/2021 7:37:44 AM Biogen Doses First Patient In Phase 3 Study Evaluating Efficacy And Safety Of BIIB059 In Systemic Lupus Erythematosus

6/16/2021 5:26:17 PM First Patient Receives Biogen's Alzheimer's Drug Aduhelm

6/15/2021 10:21:38 AM Stock Alert: Sage Therapeutics Down 15%

6/15/2021 6:52:53 AM Sage, Biogen Announce Positive Pivotal Phase 3 Results For Zuranolone - Quick Facts

6/10/2021 4:53:12 PM Two FDA Committee Members Resign Over Approval Biogen's New Alzheimer's Drug

6/10/2021 8:00:12 AM Biogen Announce New Research Supporting Development Of Investigational Higher Dose Of SPINRAZA

6/7/2021 2:28:28 PM Biogen's Aduhelm Gets FDA Approval - A New Drug For Alzheimer's In 18 Years, Priced At $56,000/Yr

6/7/2021 12:42:13 PM FDA Approves Aduhelm For Alzheimer's Treatment

6/1/2021 8:07:49 AM Biogen, Bio-Thera Say Phase 3 Study Of BAT1806 Met Its Primary Endpoints - Quick Facts

5/21/2021 7:51:03 AM Biogen, Ginkgo Bioworks Collaborate To Develop Gene Therapy Manufacturing Platform

5/14/2021 8:31:17 AM Biogen's Xirius Phase2/3 Study In XLRO Patients Fails To Meet Primary Endpoints

5/12/2021 7:51:00 AM Biogen Exercises Option To Acquire TMS-007 For Acute Ischemic Stroke - Quick Facts

5/10/2021 4:23:59 PM Biogen, Capsigen Enter Strategic Research Collaboration To Engineer Novel AAV Capsids

4/22/2021 7:27:54 AM Biogen Boosts FY21 Adj. EPS Outlook; Q1 Results Top Estimates - Quick Facts

4/22/2021 7:05:18 AM Biogen Q1 GAAP EPS $2.69; Non-GAAP EPS $5.34

4/22/2021 7:00:13 AM Biogen Q1 21 Earnings Conference Call At 8:00 AM ET

4/12/2021 8:23:08 AM Sage Therapeutics : Phase 2 Study Of SAGE-324 In Essential Tremor Meets Primary Endpoint

4/12/2021 7:04:20 AM Sage Therapeutics, Biogen: Phase 2 KINETIC Study Of SAGE-324 In Essential Tremor Meets Primary Endpoint

4/8/2021 7:41:34 AM Biogen To Gain Rights To BAT1806 From Bio-Thera - Quick Facts

4/8/2021 7:11:56 AM Biogen And Bio-Thera Solutions Enter Agreement To Develop, Manufacture And Commercialize BAT1806